Caricamento...
Rosiglitazone remodels the lipid droplet and britens human visceral and subcutaneous adipocytes ex vivo
Treatment with PPARγ agonists in vivo improves human adipocyte metabolism, but the cellular mechanisms and possible depot differences in responsiveness to their effects are poorly understood. To examine the ex vivo metabolic effects of rosiglitazone (Rosi), we cultured explants of human visceral (om...
Salvato in:
| Pubblicato in: | J Lipid Res |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
The American Society for Biochemistry and Molecular Biology
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6446708/ https://ncbi.nlm.nih.gov/pubmed/30782959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.M091173 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|